Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM.DL)

CAPS Rating: No stars

The Company is an innovation-driven biopharmaceutical company focuses on discovering, developing and commercializing medicines to change the lives of patients with cancer and inflammatory diseases.

Featured Broker Partners


Advertisement